PHARMACEUTICAL PRODUCTS GEL STATE

Brand Owner (click to sort) Address Description
ARUSTAK Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording ARUSTAK has no meaning in a foreign language.;
GEL-ARTZ Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel;GEL-ARTS;
GEL-ONE Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel for medical use;
GELIBEX Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording GELIBEX has no meaning in a foreign language.;
GELIEF Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;GEL RELIEF;The wording GELIEF has no meaning in a foreign language.;
GELLINX Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;GEL LINKS;The wording GELLINX has no meaning in a foreign language.;
GELMIRA Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording GELMIRA has no meaning in a foreign language.;
GELNAMIC Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;GEL DYNAMIC;The wording GELNAMIC has no meaning in a foreign language.;
GELTRESA Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording GELTRESA has no meaning in a foreign language.;
HYPARTZ Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel;
HYPARTZ ONE Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel for treating joint disease;HIGH PARTS ONE;
HYPERARTZ Seikagaku Kogyo Kabushiki Kaisha 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 Japan Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel;HYPER ARTS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Media and processes for the fermentation of Clostridium botulinum and obtaining a botulinum toxin for use in formulating botulinum toxin pharmaceutical compositions. The growth media can contain significantly reduced levels of meat or dairy by-products using non-animal based products to replace the animal-derived products. Preferably, the media used are substantially free of animal derived products.